Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype

被引：11

作者：

Bardet, V.

Costa, L. D.

Elie, C.

Malinge, S.

Demur, C.

Tamburini, J.

Lefebvre, P. C.

Witz, F.

Lioure, B.

Jourdan, E.

Pigneux, A.

Ifrah, N.

Attal, M.

Dreyfus, F.

Mayeux, P.

Lacombe, C.

Bennaceur-Griscelli, A.

Bernard, O. A.

Bouscary, D.

Recher, C.

机构：

[1] Univ Paris 05, Hop Cochin, APHP, Fac Med & Serv Hematol, F-75674 Paris, France

[2] Inst Cochin Genet Mol, INSERM, CNRS, U567,UMR 8104, F-75014 Paris, France

[3] Inst Gustave Roussy, Hematol Lab, Villejuif, France

[4] Hop Cochin, APHP, Serv Informat Med & Biostat, F-75674 Paris, France

[5] Hop Necker Enfants Malad, INSERM, E0210, IRNEM, Paris, France

[6] Hop Purpan, Hematol Lab, Toulouse, France

[7] UPRES, EA 3796, IFR 53, Hematol Lab, Reims, France

[8] Hop Brabois, Serv Hematol, Nancy, France

[9] Univ Hosp, Dept Hematol & Oncol, Strasbourg, France

[10] Hop Caremeau, Hematol Serv, Nimes, France

[11] Hop Dupuytren, Serv Hematol, Bordeaux, France

[12] CHU Angers, Serv Malad Sang, Angers, France

[13] Hop Purpan, Serv Hematol, Toulouse, France

来源：

LEUKEMIA | 2006年 / 20卷 / 09期

关键词：

D O I：

10.1038/sj.leu.2404294

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1644 / 1646

页数：4

共 6 条

[1] Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J].

Byrd, JC ;

Mrózek, K ;

Dodge, RK ;

Carroll, AJ ;

Edwards, CG ;

Arthur, DC ;

Pettenati, MJ ;

Patil, SR ;

Rao, KW ;

Watson, MS ;

Koduru, PRK ;

Moore, JO ;

Stone, RM ;

Mayer, RJ ;

Feldman, EJ ;

Davey, FR ;

Schiffer, CA ;

Larson, RA ;

Bloomfield, CD .

BLOOD, 2002, 100 (13) :4325-4336

[2] Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations [J].

Döhner, K ;

Schlenk, RF ;

Habdank, M ;

Scholl, C ;

Rücker, FG ;

Corbacioglu, A ;

Bullinger, L ;

Fröhling, S ;

Döhner, H .

BLOOD, 2005, 106 (12) :3740-3746

[3] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].

Falini, B ;

Mecucci, C ;

Tiacci, E ;

Alcalay, M ;

Rosati, R ;

Pasqualucci, L ;

La Starza, R ;

Diverio, D ;

Colombo, E ;

Santucci, A ;

Bigerna, B ;

Pacini, R ;

Pucciarini, A ;

Liso, A ;

Vignetti, M ;

Fazi, P ;

Meani, N ;

Pettirossi, V ;

Saglio, G ;

Mandelli, F ;

Lo-Coco, F ;

Pelicci, P ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266

[4] Dueling mutations in normal karyotype AML [J].

Gallagher, RE .

BLOOD, 2005, 106 (12) :3681-3682

[5] Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics [J].

Marcucci, G ;

Mrózek, K ;

Bloomfield, CD .

CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) :68-75

[6]

THIEDE C, 2006, IN PRESS BLOOD

← 1 →